Health ministry officials said on Thursday the decision to administer a combination of anti-HIV drugs -- lopinavir and ritonavir -- on a coronavirus-infected elderly Italian couple at a Jaipur hospital was "initially taken locally".
The hospital has been asked to inform the health ministry and the Indian Council of Medical Research (ICMR) before administering the drug combination on COVID-19 patients in future, officials said.
It was the first time that a combination of the two drugs was used to treat Covid-19 patients amid mounting coronavirus cases in India. The Italian couple are currently undergoing treatment at SMS Hospital in Jaipur.
"The decision to administer lopinavir and ritonavir combination initially was taken locally as they thought it was a severe disease and started the medicine. But we should not draw more conclusions from the same because single patient experiments do not reveal the truth more often. We need to have a structured study," Raman R Gangakhedkar, the head of the Epidemiology and Communicable Diseases-I at ICMR, said.
"Until we have a large data that come from such experiments we won't be able to infer more. But since the drug was administered we have pressed into a study mode where the samples are being regularly collected in order to see if the drug was efficacious," he said.
Dr S Meena, the medical superintendent of SMS Hospital, said the decision to administer the combination of lopinavir and ritonavir was taken after the Italian man and his wife had developed severe respiratory problems.
The Italian man, who himself is a doctor, is in ICU and on oxygen support, Meena said, adding his condition is stable.
"Even before he acquired the infection, he had some respiratory issues. Also, he is a chronic smoker. His condition had deteriorated and he developed severe respiratory problems after getting the coronavirus infection and thus was given these drugs. his condition is stable.
"His wife who also had tested positive for coronavirus has recovered and has been shifted to a different hospital," Dr Meena said.
The Drug Controller General of India (DCGI) had approved the 'restricted' use of the combination of medications, lopinavir and ritonavir, which are second-line HIV drugs, before they were administered to the elderly couple. The DCGI had given the approval after the Indian Council of Medical Research (ICMR) had sought an emergency approval for using the drugs for treating COVID- 19.
The number of coronavirus patients in the country has risen to 74. The figure includes 17 foreigners -- 16 Italian tourists and a Canadian. It also includes three patients from Kerala who were discharged last month following recovery.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
